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Dear Editor
We are writing, on behalf of the International Melioidosis Society Committee, as a
group of researchers and clinicians with longstanding experience of melioidosis and
Burkholderia pseudomallei as we have some concerns about the above paper that
was published in your journal recently.1
Although we believe that melioidosis is undoubtedly being under-diagnosed in
Indonesia,2,3 we are not convinced that the isolate in this case is B.pseudomallei
based on the information provided by the authors. Although it is difﬁcult to be
certain from the photographs in Figure 2, the colonies do not appear typical of the
species to the microbiologists amongst us, who have seen several thousand isolates
of B.pseudomallei over the past 30 years. Furthermore, the authors do not report
whether the isolate was oxidase positive or negative. We believe that more com-
prehensive methods of conﬁrming the identity, particularly genomic analysis,
should have been undertaken before publishing the case.4 Unfortunately, the post-
ampliﬁcation 16s analysis described in the paper might not have been able to
distinguish between B.pseudomallei and other Burkholderia species (particularly
B.thailandensis and several as-yet-uncharacterized Burkholderia spp.), and we
would have recommended additional testing, for example, multilocus sequence
typing and PCR for the TTS1 gene at least.
Furthermore, the resistance pattern reported, particularly to carbapenems and
ceftazidime, would be extremely unusual, especially in a patient who had not
previously received these antibiotics. Ideally, this should have been conﬁrmed
by a reference laboratory or by measuring minimum inhibitory concentrations
(eg, by broth dilution or gradient diffusion). There are as yet no internationally
accepted criteria for interpreting zone diameters for B.pseudomallei and, in our
experience, whilst disk diffusion methods are reliable for determining the sus-
ceptibility of B.pseudomallei to most agents except co-trimoxazole,5 they require
very careful quality control. Thus, even if this isolate is indeed B.pseudomallei,
it remains possible that methodological issues may have resulted in misinter-
pretation of the susceptibility results. Determination of the genetic basis for the
resistance would also be valuable.
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If indeed this was a case of melioidosis caused by
a multidrug-resistant isolate, then it is important that
as much information as possible about it is made
available to the scientiﬁc community. We have offered
to help the authors to achieve this, but have not
received a response. We, therefore, feel that we have
a duty to the scientiﬁc community to raise our
concerns.
Disclosure
The authors report no conﬂicts of interest in this
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